The Niche weekend reads: Editas mess, The Niche updates, papers
The news of the week relates to an interim clinical trial report from gene-editing firm Editas on its CRISPR trial for a form of vision loss. On to that in a minute. What have you been reading the past week? Below, I include our weekly list of recommended reads. However, first I wanted to give …
The Niche weekend reads: Editas mess, The Niche updates, papers Read More »